Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5278]

Rare cancers: a growing focus of early-stage clinical trials

Rare cancers: a growing focus of early-stage clinical trials

Engineering T cell receptors for the targeting of CMV and glioblastoma

Engineering T cell receptors for the targeting of CMV and glioblastoma

Progress in the treatment of aggressive brain tumours

Progress in the treatment of aggressive brain tumours

Combination of T cell therapy and targeted therapy as a novel strategy for therapy-resistant melanoma with mutations in the BRAF gene

Combination of T cell therapy and targeted therapy as a novel strategy for therapy-resistant melanoma with...

Drug combination may become new standard treatment for advanced kidney cancer

Drug combination may become new standard treatment for advanced kidney cancer

Advancing therapy by measuring the 'games' cancer cells play

Advancing therapy by measuring the 'games' cancer cells play

Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors

Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors

Why some brain tumours respond to immunotherapy

Why some brain tumours respond to immunotherapy

3D protein structure reveals a new mechanism for future anti-cancer drugs

3D protein structure reveals a new mechanism for future anti-cancer drugs

Sea worms and jellyfish treat cancer and kill insects

Sea worms and jellyfish treat cancer and kill insects

More from ecancer